Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia.

acute graft-versus-host disease (aGVHD) acute lymphoblastic leukaemia children hematopoietic (stem) cell transplantation management

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2021
Historique:
received: 27 09 2021
accepted: 09 12 2021
entrez: 24 1 2022
pubmed: 25 1 2022
medline: 25 1 2022
Statut: epublish

Résumé

Acute graft-versus-host disease (aGvHD) continues to be a leading cause of morbidity and mortality following allogeneic haematopoietic stem cell transplantation (HSCT). However, higher event-free survival (EFS) was observed in patients with acute lymphoblastic leukaemia (ALL) and grade II aGvHD vs. patients with no or grade I GvHD in the randomised, controlled, open-label, international, multicentre Phase III For Omitting Radiation Under Majority age (FORUM) trial. This finding suggests that moderate-severity aGvHD is associated with a graft-versus-leukaemia effect which protects against leukaemia recurrence. In order to optimise the benefits of HSCT for leukaemia patients, reduction of non-relapse mortality-which is predominantly caused by severe GvHD-is of utmost importance. Herein, we review contemporary prophylaxis and treatment options for aGvHD in children with ALL and the key challenges of aGvHD management, focusing on maintaining the graft-versus-leukaemia effect without increasing the severity of GvHD.

Identifiants

pubmed: 35071133
doi: 10.3389/fped.2021.784377
pmc: PMC8771910
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

784377

Informations de copyright

Copyright © 2022 Wölfl, Qayed, Benitez Carabante, Sykora, Bonig, Lawitschka and Diaz-de-Heredia.

Déclaration de conflit d'intérêts

CD-d-H has acted as a consultant and speaker for and has received travel expenses from Novartis. MW has acted as a consultant for and has received travel expenses from Novartis. MW also received travel expenses from Mallinckrodt Pharmaceuticals. MQ received honoraria from Mesoblasts, Medexus, Jazz Pharmaceuticals, and Novartis. HB owns IP and receives royalties and licencing fees from Medac for an MSC product for aGvHD which he co-invented. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Bone Marrow Transplant. 2015 Sep;50(9):1173-9
pubmed: 25961775
Cells. 2019 Dec 05;8(12):
pubmed: 31817480
Am J Surg Pathol. 2008 Sep;32(9):1367-72
pubmed: 18763324
Blood. 2019 Jul 18;134(3):304-316
pubmed: 31043425
Blood. 2007 May 15;109(10):4557-63
pubmed: 17244684
Blood. 2001 May 15;97(10):2962-71
pubmed: 11342418
J Immunol. 2017 Jan 1;198(1):40-46
pubmed: 27994167
Stem Cells. 2006 May;24(5):1294-301
pubmed: 16410387
Blood. 2011 Dec 15;118(25):6683-90
pubmed: 22010101
Front Immunol. 2018 Sep 25;9:2195
pubmed: 30319644
Blood. 2012 Jan 5;119(1):296-307
pubmed: 22010102
J Hematol Oncol. 2019 Sep 3;12(1):88
pubmed: 31481121
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Bone Marrow Transplant. 2014 Feb;49(2):168-73
pubmed: 23892326
Pediatr Clin North Am. 2010 Feb;57(1):273-95
pubmed: 20307721
Lancet Haematol. 2019 Jun;6(6):e306-e316
pubmed: 31078468
Br J Haematol. 2014 Feb;164(3):396-408
pubmed: 24422724
Leukemia. 2015 Oct;29(10):2062-8
pubmed: 26228813
Biol Blood Marrow Transplant. 2018 Apr;24(4):799-805
pubmed: 29288817
Blood. 2001 Mar 15;97(6):1572-7
pubmed: 11238093
Leukemia. 2010 Aug;24(8):1462-9
pubmed: 20535148
Pediatr Blood Cancer. 2018 Mar;65(3):
pubmed: 29218844
Blood. 2020 Sep 17;136(12):1442-1455
pubmed: 32542357
Lancet. 2009 May 2;373(9674):1550-61
pubmed: 19282026
Bone Marrow Transplant. 2009 Mar;43(5):423-7
pubmed: 18850021
Bone Marrow Transplant. 2014 Oct;49(10):1259-65
pubmed: 24933210
Nat Med. 2011 Nov 29;18(1):135-42
pubmed: 22127134
J Clin Invest. 2018 Nov 1;128(11):4970-4979
pubmed: 30106382
Curr Oncol Rep. 2018 Aug 3;20(9):74
pubmed: 30074106
Bone Marrow Transplant. 2018 Nov;53(11):1401-1415
pubmed: 29872128
Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10
pubmed: 26386318
Transfus Med Hemother. 2020 Jun;47(3):214-225
pubmed: 32595426
Biol Blood Marrow Transplant. 2002;8(1):40-6
pubmed: 11858189
Biol Blood Marrow Transplant. 2017 Apr;23(4):625-634
pubmed: 28104514
Biol Blood Marrow Transplant. 2018 Mar;24(3):521-528
pubmed: 29155316
Blood. 2009 Jan 8;113(2):273-8
pubmed: 18832652
Haematologica. 2015 Jun;100(6):842-8
pubmed: 25682602
Front Immunol. 2019 Jan 17;9:3179
pubmed: 30705680
Front Immunol. 2019 Aug 27;10:1879
pubmed: 31507582
Blood. 1990 Nov 1;76(9):1867-71
pubmed: 2224134
N Engl J Med. 2020 May 7;382(19):1800-1810
pubmed: 32320566
Blood. 2000 May 1;95(9):2754-9
pubmed: 10779417
Nature. 2015 Dec 24;528(7583):560-564
pubmed: 26649819
Biol Blood Marrow Transplant. 2005 Jun;11(6):465-71
pubmed: 15931635
J Clin Immunol. 2021 Jul;41(5):1016-1030
pubmed: 33651234
Cureus. 2020 Jan 25;12(1):e6774
pubmed: 32117661
J Clin Oncol. 2018 Aug 20;36(24):2514-2523
pubmed: 29863974
Biol Blood Marrow Transplant. 2020 May;26(5):e101-e112
pubmed: 31931115
Bone Marrow Transplant. 2004 Nov;34(10):901-7
pubmed: 15361908
Pediatr Hematol Oncol. 2021 May;38(4):331-345
pubmed: 33661711
Front Immunol. 2021 Apr 07;12:605726
pubmed: 33897681
Blood. 2016 Oct 20;128(16):2083-2088
pubmed: 27461930
Drug Saf. 2001;24(9):645-63
pubmed: 11522119
Bone Marrow Transplant. 2006 May;37(10):961-5
pubmed: 16565744
Blood Adv. 2019 Nov 12;3(21):3393-3405
pubmed: 31714961
Bone Marrow Transplant. 1995 May;15(5):663-8
pubmed: 7670393
Blood. 2004 Oct 1;104(7):1923-30
pubmed: 15191952
Biol Blood Marrow Transplant. 2005 Mar;11(3):194-205
pubmed: 15744238
Blood Adv. 2020 Apr 28;4(8):1656-1669
pubmed: 32324888
Bone Marrow Transplant. 2001 May;27(9):893-8
pubmed: 11436099
Bone Marrow Transplant. 2015 Feb;50(2):165-72
pubmed: 25347008
Nature. 2001 May 17;411(6835):385-9
pubmed: 11357147
Blood. 2002 Aug 15;100(4):1192-200
pubmed: 12149197
Pediatr Blood Cancer. 2021 Aug;68(8):e28968
pubmed: 33861521
Blood. 2009 Mar 26;113(13):2888-94
pubmed: 19001082
Blood. 2018 Mar 22;131(12):1372-1379
pubmed: 29437593
Transfusion. 2006 Jan;46(1):55-65
pubmed: 16398731
Bone Marrow Transplant. 2021 May;56(5):1006-1012
pubmed: 32895491
Biol Blood Marrow Transplant. 2020 Feb;26(2):351-357
pubmed: 31704470
J Clin Apher. 2006 Apr;21(1):60-4
pubmed: 16619229
Biol Blood Marrow Transplant. 2017 Jul;23(7):1122-1127
pubmed: 28344057
Biol Blood Marrow Transplant. 2018 Jun;24(6):1125-1134
pubmed: 29289756
Blood Res. 2016 Sep;51(3):152-154
pubmed: 27722122
Blood. 2007 Jun 1;109(11):5049-57
pubmed: 17327399
Br J Haematol. 1997 Jun;97(4):855-64
pubmed: 9217189
Biol Blood Marrow Transplant. 2020 May;26(5):835-844
pubmed: 31505228
Stem Cell Res Ther. 2020 Feb 18;11(1):64
pubmed: 32070420
J Clin Oncol. 2021 Jun 10;39(17):1865-1877
pubmed: 33449816
Clin Nutr. 2021 Apr;40(4):1571-1577
pubmed: 33744601
Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63
pubmed: 22510384
Pediatr Transplant. 2015 Sep;19(6):652-8
pubmed: 26103520
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076
Biol Blood Marrow Transplant. 2004 Mar;10(3):195-203
pubmed: 14993885
Blood. 2017 Mar 30;129(13):1747-1752
pubmed: 28153825
Blood. 1998 Oct 1;92(7):2303-14
pubmed: 9746768
Blood. 2020 May 14;135(20):1739-1749
pubmed: 32160294
Blood. 2000 Sep 15;96(6):2062-8
pubmed: 10979948
Cell. 2005 Sep 9;122(5):707-21
pubmed: 16143103
Am J Hematol. 2019 Mar;94(3):319-326
pubmed: 30536806
Sci Transl Med. 2010 Jan 6;2(13):13ra2
pubmed: 20371463
Biol Blood Marrow Transplant. 2015 Aug;21(8):1360-6
pubmed: 25708215
Pediatr Blood Cancer. 2020 Sep;67(9):e28233
pubmed: 32614145
J Clin Oncol. 2016 Feb 20;34(6):572-80
pubmed: 26644537
Transplantation. 2009 May 15;87(9):1422-5
pubmed: 19424046
Blood. 2007 Mar 15;109(6):2657-62
pubmed: 17110457
Front Immunol. 2017 Jul 31;8:900
pubmed: 28824628
Blood. 2012 Mar 22;119(12):2960-3
pubmed: 22286196
N Engl J Med. 2015 Oct 15;373(16):1541-52
pubmed: 26465987
Haematologica. 1998 Oct;83(10):896-903
pubmed: 9830798
Am J Hematol. 2020 Aug;95(8):927-936
pubmed: 32311156
Biol Blood Marrow Transplant. 2019 Apr;25(4):720-727
pubmed: 30468919
Bone Marrow Transplant. 2019 Feb;54(2):212-217
pubmed: 29795429
Front Immunol. 2021 Jun 18;12:697854
pubmed: 34220860
Blood. 2014 Mar 27;123(13):2017-25
pubmed: 24497539
Biol Blood Marrow Transplant. 2020 May;26(5):845-854
pubmed: 32018062
PLoS One. 2017 Aug 17;12(8):e0183284
pubmed: 28817727
Biol Blood Marrow Transplant. 2016 Jun;22(6):1087-1093
pubmed: 26900084
Br J Haematol. 2006 Nov;135(3):382-5
pubmed: 16984386
J Clin Oncol. 2021 Feb 1;39(4):295-307
pubmed: 33332189
Biol Blood Marrow Transplant. 2017 Jan;23(1):172-175
pubmed: 27777142
J Clin Oncol. 2001 Aug 15;19(16):3685-91
pubmed: 11504750
Haematologica. 2004 Nov;89(11):1352-9
pubmed: 15531458
Mini Rev Med Chem. 2015;16(3):193-9
pubmed: 26202191
Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):228-235
pubmed: 30504315
Nat Rev Cancer. 2018 May;18(5):283-295
pubmed: 29449660
Blood Adv. 2019 Dec 10;3(23):4034-4042
pubmed: 31816061
Haematologica. 2017 Dec;102(12):2125-2133
pubmed: 28971905
Transpl Int. 2020 Jul;33(7):762-772
pubmed: 32133691
Ann Hematol. 2019 Apr;98(4):971-977
pubmed: 30542943
Oncoimmunology. 2017 Jan 6;6(3):e1277307
pubmed: 28405499
Blood. 1995 Aug 1;86(3):890-9
pubmed: 7620183
Am J Surg Pathol. 2013 Sep;37(9):1319-28
pubmed: 24076772
Cancers (Basel). 2021 Aug 02;13(15):
pubmed: 34359787
Annu Rev Immunol. 2007;25:139-70
pubmed: 17129175
Biol Blood Marrow Transplant. 2016 Dec;22(12):2220-2225
pubmed: 27664325
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Immunity. 2019 Jul 16;51(1):90-103.e3
pubmed: 31278057
Bone Marrow Transplant. 2020 Jan;55(1):165-171
pubmed: 31477785
Blood. 2020 Jul 23;136(4):429-440
pubmed: 32526035
Blood Adv. 2020 Nov 24;4(22):5877-5887
pubmed: 33232479
Blood. 2017 Jun 15;129(24):3256-3261
pubmed: 28473406
Blood. 2005 Feb 15;105(4):1815-22
pubmed: 15494428
Bone Marrow Transplant. 2020 Dec;55(Suppl 1):22-174
pubmed: 33311610
Front Immunol. 2020 Oct 21;11:583564
pubmed: 33193397
Nat Immunol. 2002 Jul;3(7):611-8
pubmed: 12087419
Blood. 2018 Jun 21;131(25):2846-2855
pubmed: 29545329
Biol Blood Marrow Transplant. 2006 Jan;12(1 Suppl 2):7-12
pubmed: 16399596
Biol Blood Marrow Transplant. 2008 Jan;14(1):10-5
pubmed: 18158956
Transfus Apher Sci. 2017 Apr;56(2):118-122
pubmed: 28392150
Biol Blood Marrow Transplant. 2010 Dec;16(12):1747-8; author reply 1749
pubmed: 20601039
Bone Marrow Transplant. 2003 Nov;32(9):881-7
pubmed: 14561988
Bone Marrow Transplant. 2007 Sep;40(5):481-6
pubmed: 17618322
Blood. 2005 Sep 1;106(5):1703-10
pubmed: 15899916
Bone Marrow Transplant. 2021 Nov;56(11):2869-2870
pubmed: 34471240
Transplantation. 1974 Oct;18(4):295-304
pubmed: 4153799
J Clin Oncol. 2005 Apr 20;23(12):2661-8
pubmed: 15837980
J Clin Apher. 2019 Jun;34(3):171-354
pubmed: 31180581
Blood. 2002 Mar 15;99(6):2002-8
pubmed: 11877272
Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):843-51
pubmed: 8598361
Nature. 2013 Apr 25;496(7446):461-8
pubmed: 23467089
Transplant Cell Ther. 2021 Dec;27(12):988.e1-988.e7
pubmed: 34474163
Front Pediatr. 2021 Jul 29;9:705179
pubmed: 34395344
N Engl J Med. 2013 Aug 8;369(6):529-39
pubmed: 23924003
Bone Marrow Transplant. 2007 Sep;40(5):473-80
pubmed: 17618323
Lancet Haematol. 2020 Feb;7(2):e157-e167
pubmed: 32004485
Haematologica. 2016 Aug;101(8):985-94
pubmed: 27175026
Br J Haematol. 2012 Jul;158(1):30-45
pubmed: 22533831
Haematologica. 2016 Nov;101(11):1417-1425
pubmed: 27662016
Nature. 2010 Jun 17;465(7300):937-41
pubmed: 20559388
Haematologica. 2020 Sep 17;105(11):2550-2560
pubmed: 33054103
Bone Marrow Transplant. 2016 Aug;51(8):1087-92
pubmed: 26999466
Blood Adv. 2020 Oct 13;4(19):4980
pubmed: 33049057
Transfusion. 2018 Dec;58(12):2924-2932
pubmed: 30260547
Bone Marrow Transplant. 2003 Feb;31(3):175-81
pubmed: 12621478
Biol Blood Marrow Transplant. 2020 Nov;26(11):2053-2060
pubmed: 32682948
Bone Marrow Transplant. 2016 May;51(5):698-704
pubmed: 26808568
Transfusion. 2018 Apr;58(4):1045-1053
pubmed: 29446444
Biol Blood Marrow Transplant. 2014 Feb;20(2):229-35
pubmed: 24216185
Blood. 2011 Aug 11;118(6):1685-92
pubmed: 21636856
Bone Marrow Transplant. 2019 Jul;54(7):987-993
pubmed: 30356163
Blood. 2006 Apr 15;107(8):3074-80
pubmed: 16368882
Leuk Lymphoma. 2016;57(4):748-57
pubmed: 26457414
J Clin Oncol. 2004 May 1;22(9):1696-705
pubmed: 15117992
Transfusion. 2009 Nov;49(11):2366-73
pubmed: 19903292
Biol Blood Marrow Transplant. 2015 Apr;21(4):761-7
pubmed: 25585275
Immunity. 2019 Nov 19;51(5):885-898.e7
pubmed: 31542340
Eur J Haematol. 2004 Jul;73(1):56-61
pubmed: 15182339
Bone Marrow Transplant. 2011 Jan;46(1):143-7
pubmed: 20348971
Bone Marrow Transplant. 2003 Jun;31(11):987-93
pubmed: 12774049
Biol Blood Marrow Transplant. 2005 Aug;11(8):637-46
pubmed: 16041314
J Clin Oncol. 2015 Apr 10;33(11):1265-74
pubmed: 25753432
Br J Haematol. 2017 Apr;177(2):287-310
pubmed: 28220931
Bone Marrow Transplant. 2009 Dec;44(11):739-48
pubmed: 19377515
Pediatr Blood Cancer. 2020 Apr;67(4):e28190
pubmed: 31981413
Biol Blood Marrow Transplant. 2014 Nov;20(11):1677-86
pubmed: 24867779
Leukemia. 2002 Nov;16(11):2228-37
pubmed: 12399966
Blood. 2011 Apr 7;117(14):3921-8
pubmed: 21292771
Bone Marrow Transplant. 2020 Jun;55(6):1126-1136
pubmed: 32029909
Transplant Cell Ther. 2021 Mar;27(3):272.e1-272.e5
pubmed: 33781539
Biol Blood Marrow Transplant. 2020 Jul;26(7):1303-1311
pubmed: 32361010
Nutr Clin Pract. 2018 Aug;33(4):493-509
pubmed: 29446858

Auteurs

Matthias Wölfl (M)

Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, Würzburg University Hospital, Würzburg, Germany.

Muna Qayed (M)

Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA, United States.

Maria Isabel Benitez Carabante (MI)

Department of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.

Tomas Sykora (T)

Haematopoietic Stem Cell Transplantation Unit, Department of Pediatric Haematology and Oncology, Comenius University Children's Hospital, Bratislava, Slovakia.

Halvard Bonig (H)

Institute for Transfusion Medicine and Immunohematology, Goethe-University Frankfurt/Main, Frankfurt, Germany.
German Red Cross Blood Service BaWüHe, Frankfurt, Germany.

Anita Lawitschka (A)

Department of Pediatrics, St. Anna Kinderspital and Children's Cancer Research Institute, Medical University of Vienna, Vienna, Austria.

Cristina Diaz-de-Heredia (C)

Department of Pediatric Hematology and Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain.

Classifications MeSH